Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children

Condition(s) studied

Investigational drug(s) / intervention(s)

CBP: continuous blood purification can prevent or treat fluid overload in children with septic shock or other sepsis-associated organ dysfunction who are unresponsive to fluid restriction and diuretic therapy management of septic AKI patients, particularly those with hemodynamic instability or fluid overload. Also, it can remove cytokines

Study summary

The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.

Eligibility

Primary outcome measure(s)

• survival rate — 28 days after hospital discharge
  The survival rate of children in 28 days after hospital discharge

Trial sites (1)

More Children's Hospital of Fudan University trials in China

Other trials for the same condition